$AMBA
AMBARELLA INC

2016 Q2 Form 10-Q Financial Statement

#000156459017012295 Filed on June 08, 2017

View on sec.gov

Income Statement

Concept 2016 Q2
Revenue $57.16M
YoY Change -19.51%
Cost Of Revenue $20.45M
YoY Change -18.51%
Gross Profit $36.71M
YoY Change -20.06%
Gross Profit Margin 64.22%
Selling, General & Admin $10.89M
YoY Change 20.9%
% of Gross Profit 29.68%
Research & Development $24.47M
YoY Change 47.54%
% of Gross Profit 66.65%
Depreciation & Amortization $464.0K
YoY Change 26.43%
% of Gross Profit 1.26%
Operating Expenses $35.36M
YoY Change 38.16%
Operating Profit $1.348M
YoY Change -93.37%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $27.00K
YoY Change 0.0%
Pretax Income $1.375M
YoY Change -93.24%
Income Tax -$408.0K
% Of Pretax Income -29.67%
Net Earnings $1.783M
YoY Change -90.54%
Net Earnings / Revenue 3.12%
Basic Earnings Per Share $0.05
Diluted Earnings Per Share $0.05
COMMON SHARES
Basic Shares Outstanding 32.43M
Diluted Shares Outstanding 33.95M

Balance Sheet

Concept 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $323.8M
YoY Change 37.67%
Cash & Equivalents $268.0M
Short-Term Investments $55.85M
Other Short-Term Assets $3.800M
YoY Change -20.83%
Inventory $17.92M
Prepaid Expenses
Receivables $30.50M
Other Receivables $0.00
Total Short-Term Assets $376.1M
YoY Change 23.31%
LONG-TERM ASSETS
Property, Plant & Equipment $3.567M
YoY Change 18.9%
Goodwill $26.60M
YoY Change
Intangibles $4.173M
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.085M
YoY Change 8.14%
Total Long-Term Assets $42.97M
YoY Change 381.26%
TOTAL ASSETS
Total Short-Term Assets $376.1M
Total Long-Term Assets $42.97M
Total Assets $419.1M
YoY Change 33.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.35M
YoY Change -31.86%
Accrued Expenses $17.40M
YoY Change 13.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $39.83M
YoY Change -15.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $2.767M
YoY Change 72.94%
Total Long-Term Liabilities $2.767M
YoY Change 72.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.83M
Total Long-Term Liabilities $2.767M
Total Liabilities $42.60M
YoY Change -12.16%
SHAREHOLDERS EQUITY
Retained Earnings $186.4M
YoY Change
Common Stock $15.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $376.5M
YoY Change
Total Liabilities & Shareholders Equity $419.1M
YoY Change 33.5%

Cashflow Statement

Concept 2016 Q2
OPERATING ACTIVITIES
Net Income $1.783M
YoY Change -90.54%
Depreciation, Depletion And Amortization $464.0K
YoY Change 26.43%
Cash From Operating Activities $15.60M
YoY Change -37.1%
INVESTING ACTIVITIES
Capital Expenditures $469.0K
YoY Change 24.73%
Acquisitions
YoY Change
Other Investing Activities -$16.10M
YoY Change 3120.0%
Cash From Investing Activities -$16.60M
YoY Change 1975.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 900.0K
YoY Change -70.97%
NET CHANGE
Cash From Operating Activities 15.60M
Cash From Investing Activities -16.60M
Cash From Financing Activities 900.0K
Net Change In Cash -100.0K
YoY Change -100.37%
FREE CASH FLOW
Cash From Operating Activities $15.60M
Capital Expenditures $469.0K
Free Cash Flow $15.13M
YoY Change -38.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 amba Increase Decrease In Deferred Tax Liabilities
IncreaseDecreaseInDeferredTaxLiabilities
0
CY2016Q2 amba Increase Decrease In Deferred Tax Liabilities
IncreaseDecreaseInDeferredTaxLiabilities
-58000
CY2017Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1870000
CY2016Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3985000
CY2017Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
11000
CY2016Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23023000
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
15550000
CY2017Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
7070000
CY2016Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
35857000
CY2017Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1000000
CY2016Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
8974000
CY2017Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3490000
CY2016Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
10790000
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
955000
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
469000
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3535000
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16562000
CY2017Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8773000
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2017Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1595000
CY2016Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
915000
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-7178000
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
915000
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12310000
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-97000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
268056000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267959000
CY2017Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
290000
CY2016Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
241000
CY2017Q2 amba Capital Expenditures Incurred But Not Yet Paid And Financing Incurred For Intangible And Fixed Asset Purchases
CapitalExpendituresIncurredButNotYetPaidAndFinancingIncurredForIntangibleAndFixedAssetPurchases
9937000
CY2016Q2 amba Capital Expenditures Incurred But Not Yet Paid And Financing Incurred For Intangible And Fixed Asset Purchases
CapitalExpendituresIncurredButNotYetPaidAndFinancingIncurredForIntangibleAndFixedAssetPurchases
153000
CY2017Q2 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, management evaluates its estimates and assumptions, including those related to (i)&#160;the collectibility of accounts receivable; (ii)&#160;write down of excess and obsolete inventories; (iii) intangible assets and goodwill; (iv)&#160;the estimated useful lives of long-lived assets; (v)&#160;impairment of long-lived assets and financial instruments; (vi)&#160;warranty obligations; (vii)&#160;the valuation of stock-based compensation awards and financial instruments; (viii)&#160;the probability of performance objectives achievement; (ix)&#160;the realization of tax assets and estimates of tax liabilities, including reserves for uncertain tax positions; and (x)&#160;the recognition and disclosure of contingent liabilities. These estimates and assumptions are based on historical experience and on various other factors which the Company believes to be reasonable under the circumstances. The Company may engage third-party valuation specialists to assist with estimates related to the valuation of financial instruments and assets associated with various contractual arrangements. Such estimates often require the selection of appropriate valuation methodologies and significant judgment. Actual results could differ from these estimates under different assumptions or circumstances.</p></div>
CY2017Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
101146000
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
100920000
CY2017Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2017Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000
CY2017Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
95000
CY2017Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
83000
CY2017Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
101058000
CY2017Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100850000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
90440000
CY2017Q1 amba Available For Sale Securities Debt Maturities Within One To Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneToTwoYearsFairValue
23858000
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10209000
CY2017Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10105000
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8857000
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10040000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13962000
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13427000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8721000
CY2017Q2 amba Available For Sale Securities Debt Maturities Within One To Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneToTwoYearsFairValue
10618000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
76992000
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8439000
CY2017Q2 amba Capitalized Noncancelable Internal Use Software License Gross
CapitalizedNoncancelableInternalUseSoftwareLicenseGross
9800000
CY2017Q2 amba Noncancelable Internal Use Software License Amortization
NoncancelableInternalUseSoftwareLicenseAmortization
300000
CY2017Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2016Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2017Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8675000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14685000
CY2017Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
800000
CY2017Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
500000
CY2017Q2 amba Accrued Rebates
AccruedRebates
951000
CY2017Q1 amba Accrued Rebates
AccruedRebates
972000
CY2017Q2 amba Accrued Development Cost Liabilities
AccruedDevelopmentCostLiabilities
5152000
CY2017Q1 amba Accrued Development Cost Liabilities
AccruedDevelopmentCostLiabilities
7605000
CY2017Q2 amba Software License Liabilities Current
SoftwareLicenseLiabilitiesCurrent
3177000
CY2017Q1 amba Software License Liabilities Current
SoftwareLicenseLiabilitiesCurrent
0
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2174000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2686000
CY2017Q2 amba Deferred Revenue From Product Shipments
DeferredRevenueFromProductShipments
6211000
CY2017Q1 amba Deferred Revenue From Product Shipments
DeferredRevenueFromProductShipments
7725000
CY2017Q2 amba Deferred Revenue From Licenses Services
DeferredRevenueFromLicensesServices
1036000
CY2017Q1 amba Deferred Revenue From Licenses Services
DeferredRevenueFromLicensesServices
1748000
CY2017Q2 amba Deferred Cost Of Revenue From Product Shipments
DeferredCostOfRevenueFromProductShipments
1692000
CY2017Q1 amba Deferred Cost Of Revenue From Product Shipments
DeferredCostOfRevenueFromProductShipments
2048000
CY2017Q2 amba Unrecognized Tax Benefits Including Interest
UnrecognizedTaxBenefitsIncludingInterest
1916000
CY2017Q1 amba Unrecognized Tax Benefits Including Interest
UnrecognizedTaxBenefitsIncludingInterest
1905000
CY2017Q2 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
1333000
CY2017Q1 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
1333000
CY2017Q2 amba Software License Liabilities Non Current
SoftwareLicenseLiabilitiesNonCurrent
5751000
CY2017Q1 amba Software License Liabilities Non Current
SoftwareLicenseLiabilitiesNonCurrent
0
CY2017Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
2000
CY2017Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3000
CY2016Q4 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2017-06-30
CY2016Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P6M
CY2017Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
162738
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
567827
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29000000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12972000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11301000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1703524
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50600
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
47480
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6063
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2945
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1697636
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1363740
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.66
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
56.27
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
29.23
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2080000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
6425
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200796
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1716997
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.074
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y15D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M27D
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.297
CY2017Q2 amba Minimum Percentage Of Voting Stock Used To Define Related Party
MinimumPercentageOfVotingStockUsedToDefineRelatedParty
0.10
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
59542000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
56306000
CY2017Q2 amba Closing Market Price Of Ordinary Shares On Nasdaq On Last Day Of Reporting Period
ClosingMarketPriceOfOrdinarySharesOnNASDAQOnLastDayOfReportingPeriod
56.22
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1006149
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1050288
CY2017Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
422744
CY2016Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
465976
CY2017Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
2371
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.23
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
61.45
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
64.60
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.74
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.85

Files In Submission

Name View Source Status
0001564590-17-012295-index-headers.html Edgar Link pending
0001564590-17-012295-index.html Edgar Link pending
0001564590-17-012295.txt Edgar Link pending
0001564590-17-012295-xbrl.zip Edgar Link pending
amba-10q_20170430.htm Edgar Link pending
amba-20170430.xml Edgar Link completed
amba-20170430.xsd Edgar Link pending
amba-20170430_cal.xml Edgar Link unprocessable
amba-20170430_def.xml Edgar Link unprocessable
amba-20170430_lab.xml Edgar Link unprocessable
amba-20170430_pre.xml Edgar Link unprocessable
amba-ex311_6.htm Edgar Link pending
amba-ex312_7.htm Edgar Link pending
amba-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending